Dr Steve Tregay, Managing General Partner of Mission BioCapital, and Chairman of Lab Central, joins the first episode of Biotech Frontiers for a discussion on how to build enduring, innovative biotech ventures. Drawing on his deep experience as a founder and investor, Steve considers the transformative power of innovation clusters, and the future of venture creation in biotech.

Steve Tregay, PhD is a Managing General Partner of Mission BioCapital, based in their Cambridge office. He focuses on new therapeutics investments with a particular emphasis on company creation opportunities. Within the Mission BioCapital portfolio, he is currently founding CEO and board member of Arclight Therapeutics, LLC, a founding board member at Jupiter BioVentures LLC, and has board roles at Vedere Bio and Nocion Therapeutics. In addition, Steve serves as Chairman of the Board of Directors at LabCentral. He is a Harvard Blavatnik Biomedical Accelerator Advisory Committee member and is a member of the board of advisors for the non-profit Life Sciences Cares. 

Previously, Steve was the Founder and CEO of FORMA Therapeutics. Additional roles held prior to his engagement at FORMA include Managing Director for the Novartis Venture Fund and Executive Director & Head of Strategic Alliances for Oncology, Ophthalmology and Technologies at the Novartis Institutes for BioMedical Research. Prior to Novartis, he held roles in research and business development at Array BioPharma.

Steve received his doctoral and Master’s degrees in organic chemistry from Harvard University and a Bachelor’s from Davidson College.